Total Payments
$352,577
2024 Payments
$51,353
Companies
52
Transactions
1,373
Medicare Patients
27,289
Medicare Billing
$2.0M
Payment Breakdown by Category
Other$229,968 (65.2%)
Consulting$75,072 (21.3%)
Food & Beverage$33,745 (9.6%)
Travel$13,056 (3.7%)
Education$735.73 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $212,838 | 128 | 60.4% |
| Consulting Fee | $75,072 | 42 | 21.3% |
| Food and Beverage | $33,745 | 1,134 | 9.6% |
| Honoraria | $17,131 | 10 | 4.9% |
| Travel and Lodging | $13,056 | 43 | 3.7% |
| Education | $735.73 | 16 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $99,057 | 130 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $40,931 | 159 | $0 (2024) |
| Lilly USA, LLC | $31,877 | 86 | $0 (2024) |
| UCB, Inc. | $26,067 | 68 | $0 (2024) |
| Genentech USA, Inc. | $21,307 | 31 | $0 (2024) |
| Incyte Corporation | $21,041 | 33 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $19,295 | 65 | $0 (2024) |
| ABBVIE INC. | $16,082 | 145 | $0 (2024) |
| Galderma Laboratories, L.P. | $13,183 | 54 | $0 (2024) |
| LEO Pharma Inc. | $8,732 | 49 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $51,353 | 199 | Lilly USA, LLC ($11,394) |
| 2023 | $56,405 | 187 | Lilly USA, LLC ($16,036) |
| 2022 | $44,726 | 192 | PFIZER INC. ($19,190) |
| 2021 | $18,483 | 156 | UCB, Inc. ($6,433) |
| 2020 | $9,792 | 126 | Novartis Pharmaceuticals Corporation ($2,663) |
| 2019 | $71,828 | 193 | PFIZER INC. ($29,479) |
| 2018 | $54,190 | 173 | PFIZER INC. ($27,799) |
| 2017 | $45,799 | 147 | PFIZER INC. ($14,214) |
All Payment Transactions
1,373 individual payment records from CMS Open Payments — Page 1 of 55
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | ABBVIE INC. | SKYRIZI (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,350.00 | General |
| Category: IMMUNOLOGY | ||||||
| 12/18/2024 | Verrica Pharmaceuticals Inc. | YCANTH (Drug) | Food and Beverage | In-kind items and services | $19.61 | General |
| Category: DERMATOLOGY | ||||||
| 12/17/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $16.05 | General |
| Category: Immunology | ||||||
| 12/11/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $10.97 | General |
| Category: Immunology | ||||||
| 12/10/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $44.71 | General |
| Category: Immunology | ||||||
| 12/10/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $8.32 | General |
| Category: Immunology | ||||||
| 12/05/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $28.18 | General |
| Category: DERMATOLOGY | ||||||
| 12/05/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $23.75 | General |
| Category: Immunology | ||||||
| 12/03/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $23.42 | General |
| Category: IMMUNOLOGY | ||||||
| 12/03/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $16.49 | General |
| Category: Immunology | ||||||
| 12/02/2024 | ABBVIE INC. | SKYRIZI (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,350.00 | General |
| Category: IMMUNOLOGY | ||||||
| 12/02/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Education | In-kind items and services | $82.95 | General |
| Category: Immunology | ||||||
| 11/26/2024 | Incyte Corporation | — | Consulting Fee | Cash or cash equivalent | $1,800.00 | General |
| 11/20/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $14.87 | General |
| Category: DERMATOLOGY | ||||||
| 11/20/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $7.69 | General |
| Category: DERMATOLOGY | ||||||
| 11/20/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $5.65 | General |
| Category: Immunology | ||||||
| 11/19/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $15.32 | General |
| Category: IMMUNOLOGY | ||||||
| 11/19/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $8.66 | General |
| Category: Immunology | ||||||
| 11/18/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $1.73 | General |
| Category: Dermatology | ||||||
| 11/14/2024 | Lilly USA, LLC | EBGLYSS (Drug) | Food and Beverage | In-kind items and services | $102.83 | General |
| Category: Immunology | ||||||
| 11/14/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $26.98 | General |
| Category: Immunology | ||||||
| 11/13/2024 | Galderma Laboratories, L.P. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,600.00 | General |
| 11/13/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $22.49 | General |
| Category: Dermatology | ||||||
| 11/06/2024 | Lilly USA, LLC | EBGLYSS (Drug) | Food and Beverage | In-kind items and services | $20.25 | General |
| Category: Immunology | ||||||
| 11/06/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $7.75 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 27 | 5,735 | 11,080 | $1.4M | $444,948 |
| 2022 | 25 | 5,959 | 12,191 | $1.2M | $394,413 |
| 2021 | 28 | 7,175 | 15,077 | $1.8M | $554,038 |
| 2020 | 31 | 8,420 | 23,131 | $2.3M | $608,996 |
Total Patients
27,289
Total Services
61,479
Medicare Billing
$2.0M
Procedure Codes
111
All Medicare Procedures & Services
111 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 1,200 | 1,549 | $162,645 | $88,162 | 54.2% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 1,114 | 1,506 | $171,684 | $58,407 | 34.0% |
| 13132 | Complicated repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet, 2.6-7.5 cm | Office | 2023 | 121 | 148 | $189,292 | $51,303 | 27.1% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 464 | 510 | $76,500 | $33,328 | 43.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 245 | 293 | $51,568 | $23,722 | 46.0% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 845 | 5,119 | $194,522 | $21,835 | 11.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 464 | 538 | $40,888 | $18,978 | 46.4% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 125 | 153 | $68,850 | $17,611 | 25.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 236 | 236 | $34,928 | $16,431 | 47.0% |
| 13152 | Complicated repair of wound of eyelids, nose, ears, or lip, 2.6-7.5 cm | Office | 2023 | 40 | 42 | $63,630 | $15,474 | 24.3% |
| 13121 | Complicated repair of wound of scalp, arms, or legs, 2.6-7.5 cm | Office | 2023 | 43 | 48 | $28,560 | $14,967 | 52.4% |
| 11642 | Removal of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm | Office | 2023 | 119 | 147 | $98,784 | $14,309 | 14.5% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 63 | 66 | $28,248 | $14,156 | 50.1% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 166 | 184 | $27,416 | $13,741 | 50.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 75 | 75 | $15,375 | $7,847 | 51.0% |
| 11602 | Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 73 | 86 | $36,722 | $7,612 | 20.7% |
| 12042 | Intermediate repair of wound of neck, hands, feet, or genitals, 2.6-7.5 cm | Office | 2023 | 23 | 24 | $11,208 | $5,354 | 47.8% |
| 11622 | Removal of cancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm | Office | 2023 | 42 | 49 | $28,567 | $4,557 | 16.0% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 70 | 95 | $8,550 | $3,361 | 39.3% |
| 11200 | Removal of skin tag, 1-15 skin tags | Office | 2023 | 60 | 63 | $7,875 | $3,266 | 41.5% |
| 11603 | Removal of cancer skin growth of body, arms, or legs, 2.1-3.0 cm | Office | 2023 | 29 | 30 | $15,420 | $2,885 | 18.7% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 40 | 40 | $5,280 | $1,767 | 33.5% |
| 11623 | Removal of cancer skin growth of scalp, neck, hands, feet, or genitals, 2.1-3.0 cm | Office | 2023 | 15 | 15 | $9,540 | $1,643 | 17.2% |
| 10060 | Simple or single drainage of skin abscess | Office | 2023 | 18 | 18 | $3,366 | $1,380 | 41.0% |
| 11643 | Removal of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 2.1-3.0 cm | Office | 2023 | 11 | 11 | $8,437 | $1,217 | 14.4% |
About Jason Smith, M D
Jason Smith, M D is a Procedural Dermatology healthcare provider based in Rome, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/25/2006. The National Provider Identifier (NPI) number assigned to this provider is 1578586400.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Jason Smith, M D has received a total of $352,577 in payments from pharmaceutical and medical device companies, with $51,353 received in 2024. These payments were reported across 1,373 transactions from 52 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($212,838).
As a Medicare-enrolled provider, Smith has provided services to 27,289 Medicare beneficiaries, totaling 61,479 services with total Medicare billing of $2.0M. Data is available for 4 years (2020–2023), covering 111 distinct procedure/service records.
Ad
Practice Information
- Specialty Procedural Dermatology
- Location Rome, GA
- Active Since 07/25/2006
- Last Updated 02/16/2010
- Taxonomy Code 207NS0135X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1578586400
Products in Payments
- EUCRISA (Drug) $76,260
- COSENTYX (Biological) $40,081
- OLUMIANT (Drug) $26,029
- CIBINQO (Drug) $22,755
- Erivedge (Biological) $21,307
- SKYRIZI (Biological) $12,781
- Bimzelx (Biological) $12,129
- ILUMYA (Biological) $10,604
- ADBRY (Biological) $8,181
- Cimzia (Drug) $6,754
- ILUMYA (tildrakizumab-asmn) injection (Biological) $6,516
- OPZELURA (Drug) $4,575
- SEYSARA (Drug) $3,935
- Sitavig (Drug) $3,912
- Olumiant (Drug) $3,750
- DUPIXENT (Biological) $2,945
- Seysara (Drug) $2,756
- YCANTH (Drug) $2,672
- EPIDUO FORTE (Drug) $2,409
- ACZONE (Drug) $2,041
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.